2023

article thumbnail

Top 10 Journal Articles To Read During Your Infectious Diseases Pharmacy Rotation

IDStewardship

In this post a top 10 list of journal articles to read during an infectious diseases pharmacy rotation is provided. Authored by: Timothy P. Gauthier, Pharm.D.,

article thumbnail

FDA pulls AZ’s Evusheld for COVID, citing lack of efficacy

Pharma Phorum

AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Congress Probes PBM Link to Higher Drug Prices

PharmExec

Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.

126
126
article thumbnail

‘The Last of Us’ might be fiction, but fungi are a looming threat

PharmaVoice

Fungal infections are a growing challenge for hospitalized patients, and new treatments are badly needed

Hospitals 122
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Wearable Device Accurately Tracks Heart Failure Progression

Pharmacy Times

Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.

181
181
article thumbnail

Scottish biotech aims to cure common cold

Pharmafile

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure for the common cold from algae.

More Trending

article thumbnail

First nasal monoclonal antibody COVID-19 treatment shows potential

European Pharmaceutical Review

A pilot study has demonstrated that a nasal version of the drug Foralumab, an anti-CD3 monoclonal antibody suppressed the inflammatory T cell response and decreased lung inflammation in patients with COVID-19.

article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

For a long time, aging biology and research have been enigmatic areas that biotechs hoped to capitalise on due to their market potential.

Labelling 145
article thumbnail

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license

Fierce Pharma

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18

Vaccines 145
article thumbnail

Employee Spotlight: Rob Moore

InCrowd

Rob Moore the Director of Information Technology for Apollo Intelligence. Get to know more about him below! Tell us about your role: I’m the Director of Information Technology for Apollo Intelligence. Apollo Intelligence supports market insights brands in the life science space.

article thumbnail

Partnering With Microbiology Laboratory To Bring Awareness To Antimicrobial Resistance

IDStewardship

In this article three infectious diseases pharmacists discuss the cross-roads of antimicrobial resistance and microbiology laboratory, reflecting on a recent Twitter chat on the topic.

Hospitals 130
article thumbnail

Google and DeepMind share work on medical chatbot Med-PaLM

Pharma Phorum

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.

136
136
article thumbnail

Indegene Launches Metaverse Capabilities

PharmExec

The capabilities will support life sciences organizations with a variety of use cases, including health care provider (HCP) interactions, HCP education, and patient education.

126
126
article thumbnail

Woman of the Week: Psilera’s Jackie von Salm

PharmaVoice

Psilera founder’s “third eye” approach to psychedelics ushers them into the therapeutic realm

105
105
article thumbnail

Speech Therapy May Effectively Address Long COVID Communication Issues

Pharmacy Times

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

article thumbnail

Sun Pharma recalls at least 34,000 bottles of generic drug

Pharmafile

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, from the US market. The drug is used for treating high blood pressure, angina and some types of irregular heartbeat.

FDA 115
article thumbnail

Major coalition of health groups aims to combat health misinformation

Fierce Healthcare

Major coalition of health groups aims to combat health misinformation rking Fri, 02/24/2023 - 11:17

145
145
article thumbnail

Disruptive Factors Shape RA Landscape

Pharmaceutical Commerce

As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

98
article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

Earlier this week, the Florida Senate advanced a bill to restrict gender-affirming care for transgender minors. The bill is one of many that are currently being discussed in different states.

Labelling 135
article thumbnail

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit

Fierce Pharma

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit kdunleavy Tue, 02/14/2023 - 10:29

145
145
article thumbnail

Pharma Marketers Need AI Now: How to deliver a truly personalized, omnichannel experience for your patients, with William Grambley, CEO of Allazo Health

Pharma Marketing Network

Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged.

96
article thumbnail

Kite releases pivotal CAR T therapy Phase III study results

European Pharmaceutical Review

Primary overall survival (OS) analysis results from Kite’s Phase III ZUMA-7 study showed a statistically significant improvement for CAR T-cell therapy Yescarta ® in OS versus historical treatment.

article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

Pharma Phorum

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

article thumbnail

Governing Principles for Successful Biotechnology Companies

PharmExec

Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.

118
118
article thumbnail

This biotech CEO secured two billion-dollar Big Pharma deals during the pandemic

PharmaVoice

With the industry focused on cancer and COVID-19, Marc de Garidel made deals centered on cardio

116
116
article thumbnail

Study Shows That Breast Milk of Those Vaccinated Against COVID-19 Protects Infants

Pharmacy Times

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Vaccines 167
article thumbnail

Occlutech launches FROST-HF study of heart failure device

Pharmafile

Occlutech has announced that it has recruited its first patient in the FROST-HF study, which aims to investigate the company’s atrial flow regulator (AFR) device to treat patients with heart failure.

103
103
article thumbnail

Doximity rolls out beta version of ChatGPT tool for docs aiming to streamline administrative paperwork

Fierce Healthcare

Doximity rolls out beta version of ChatGPT tool for docs aiming to streamline administrative paperwork hlandi Sat, 02/11/2023 - 05:02

145
145
article thumbnail

2023 Fundraising Challenges

NF2 BioSolutions

We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE.

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution.

Packaging 142
article thumbnail

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

Fierce Pharma

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29

145
145
article thumbnail

Physician Opinions on Burnout in 2022 – Blog

InCrowd

In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels.

91
article thumbnail

Mass spectrometry software can link different data types

European Pharmaceutical Review

The latest version of software tool MZmine, which aids analysis of mass spectrometry data, has been released. Using this third generation software, scientists can analyse large volumes of data from mass spectrometry, processing thousands of samples within minutes to hours.

article thumbnail

The importance of AI literacy in life sciences

Pharma Phorum

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

article thumbnail

Generative AI’s Breakthrough Potential in Pharma Marketing

PharmExec

How platforms like ChatGPT could transform engagement models.

111
111
article thumbnail

SCOTUS to decide ‘fundamental change’ in biologics patents with fate of Amgen v. Sanofi

PharmaVoice

The Supreme Court will now decide whether Amgen can protect Repatha as a whole class of drugs or whether Sanofi’s rival product Praluent can retain a place in the market

98